Login
Home
Charts
Search
Watchlist
Products

EPL Ltd

EPL·NSE
236.65-1.25%Tue, 22 Sept '26

EPL Ltd

EPL
NSE
236.65
-1.25%
|Tue, 22 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
7,583Cr
Close
Close Price
236.75
Industry
Industry
Packaging - FMCG/Consumers
PE
Price To Earnings
19.55
PS
Price To Sales
1.50
Revenue
Revenue
5,043Cr
Rev Gr TTM
Revenue Growth TTM
16.91%
PAT Gr TTM
PAT Growth TTM
-1.60%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
1,0029751,0291,0071,0861,0141,1051,1081,2061,1491,3011,388
Growth YoY
Revenue Growth YoY%
5.63.26.210.78.44.07.410.011.013.317.625.3
Expenses
ExpensesCr
8217928388228668138778819549181,0441,127
Operating Profit
Operating ProfitCr
181183191186221202228227252231256261
OPM
OPM%
18.118.818.618.420.319.920.620.520.920.119.718.8
Other Income
Other IncomeCr
1125-4461213118122-76
Interest Expense
Interest ExpenseCr
312932292927282829292929
Depreciation
DepreciationCr
84848584858688909497104109
PBT
PBTCr
78943080118101123117141107116129
Tax
TaxCr
257151430671635241228
PAT
PATCr
52871566889411610110683103101
Growth YoY
PAT Growth YoY%
9.438.6-82.318.269.57.8666.254.320.2-11.7-10.7-0.8
NPM
NPM%
5.28.91.56.58.19.310.59.28.87.27.97.3
EPS
EPS
1.62.70.72.02.72.93.63.13.32.53.23.1
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
1,0029751,0291,0071,0861,0141,1051,1081,2061,1491,3011,388
Growth YoY
Revenue Growth YoY%
5.63.26.210.78.44.07.410.011.013.317.625.3
Expenses
ExpensesCr
8217928388228668138778819549181,0441,127
Operating Profit
Operating ProfitCr
181183191186221202228227252231256261
OPM
OPM%
18.118.818.618.420.319.920.620.520.920.119.718.8
Other Income
Other IncomeCr
1125-4461213118122-76
Interest Expense
Interest ExpenseCr
312932292927282829292929
Depreciation
DepreciationCr
84848584858688909497104109
PBT
PBTCr
78943080118101123117141107116129
Tax
TaxCr
257151430671635241228
PAT
PATCr
52871566889411610110683103101
Growth YoY
PAT Growth YoY%
9.438.6-82.318.269.57.8666.254.320.2-11.7-10.7-0.8
NPM
NPM%
5.28.91.56.58.19.310.59.28.87.27.97.3
EPS
EPS
1.62.70.72.02.72.93.63.13.32.53.23.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
2,1282,3022,4242,7072,7613,0923,4333,6943,9164,2134,7635,043
Growth
Revenue Growth%
-8.48.25.311.72.012.011.07.66.07.613.116.9
Expenses
ExpensesCr
1,7241,8801,9592,2082,2042,4812,8573,1163,2023,3773,7984,043
Operating Profit
Operating ProfitCr
4044224654995586115765787148369661,000
OPM
OPM%
19.018.319.218.420.219.816.815.618.219.820.319.8
Other Income
Other IncomeCr
315220373-34382421513
Interest Expense
Interest ExpenseCr
6158556156434067116114115116
Depreciation
DepreciationCr
123141167186230235251281333343385405
PBT
PBTCr
251274263289275331289268268422481492
Tax
TaxCr
787989936487683758588799
PAT
PATCr
173196174195212244221231210364394393
Growth
PAT Growth%
19.413.0-10.912.28.315.4-9.44.3-8.973.28.3-1.6
NPM
NPM%
8.18.57.27.27.77.96.56.35.48.68.37.8
EPS
EPS
5.46.12.76.16.67.66.87.26.711.312.212.1
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
2,1282,3022,4242,7072,7613,0923,4333,6943,9164,2134,7635,043
Growth
Revenue Growth%
-8.48.25.311.72.012.011.07.66.07.613.116.9
Expenses
ExpensesCr
1,7241,8801,9592,2082,2042,4812,8573,1163,2023,3773,7984,043
Operating Profit
Operating ProfitCr
4044224654995586115765787148369661,000
OPM
OPM%
19.018.319.218.420.219.816.815.618.219.820.319.8
Other Income
Other IncomeCr
315220373-34382421513
Interest Expense
Interest ExpenseCr
6158556156434067116114115116
Depreciation
DepreciationCr
123141167186230235251281333343385405
PBT
PBTCr
251274263289275331289268268422481492
Tax
TaxCr
787989936487683758588799
PAT
PATCr
173196174195212244221231210364394393
Growth
PAT Growth%
19.413.0-10.912.28.315.4-9.44.3-8.973.28.3-1.6
NPM
NPM%
8.18.57.27.27.77.96.56.35.48.68.37.8
EPS
EPS
5.46.12.76.16.67.66.87.26.711.312.212.1

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
3131316363636364646464
Reserves
ReservesCr
9331,0081,2191,3251,4701,6351,7611,9262,0282,2912,793
Current Liabilities
Current LiabilitiesCr
4435456665747927738969631,0841,1521,356
Non Current Liabilities
Non Current LiabilitiesCr
603669522553472507537677634495677
Total Liabilities
Total LiabilitiesCr
2,0192,2592,4422,5202,8063,0113,2913,6323,8094,0064,900
Current Assets
Current AssetsCr
9229641,1341,0931,3401,3441,5321,6231,6471,7342,119
Non Current Assets
Non Current AssetsCr
1,0971,2951,3081,4271,4661,6671,7592,0102,1622,2712,781
Total Assets
Total AssetsCr
2,0192,2592,4422,5202,8063,0113,2913,6323,8094,0064,900
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
3131316363636364646464
Reserves
ReservesCr
9331,0081,2191,3251,4701,6351,7611,9262,0282,2912,793
Current Liabilities
Current LiabilitiesCr
4435456665747927738969631,0841,1521,356
Non Current Liabilities
Non Current LiabilitiesCr
603669522553472507537677634495677
Total Liabilities
Total LiabilitiesCr
2,0192,2592,4422,5202,8063,0113,2913,6323,8094,0064,900
Current Assets
Current AssetsCr
9229641,1341,0931,3401,3441,5321,6231,6471,7342,119
Non Current Assets
Non Current AssetsCr
1,0971,2951,3081,4271,4661,6671,7592,0102,1622,2712,781
Total Assets
Total AssetsCr
2,0192,2592,4422,5202,8063,0113,2913,6323,8094,0064,900

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
361369343356471522312602587795723
Investing Cash Flow
Investing Cash FlowCr
-46-301-156-188-119-281-264-389-344-376-452
Financing Cash Flow
Financing Cash FlowCr
-320-76-154-194-142-319-95-138-263-431-274
Net Cash Flow
Net Cash FlowCr
-5-934-25210-77-4874-21-12-3
Free Cash Flow
Free Cash FlowCr
16516220656364526320606589802731
CFO To PAT
CFO To PAT%
208.4188.5197.2182.4222.6213.8140.8260.9279.1218.6183.5
CFO To EBITDA
CFO To EBITDA%
89.487.473.971.484.585.554.1104.282.195.174.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
361369343356471522312602587795723
Investing Cash Flow
Investing Cash FlowCr
-46-301-156-188-119-281-264-389-344-376-452
Financing Cash Flow
Financing Cash FlowCr
-320-76-154-194-142-319-95-138-263-431-274
Net Cash Flow
Net Cash FlowCr
-5-934-25210-77-4874-21-12-3
Free Cash Flow
Free Cash FlowCr
16516220656364526320606589802731
CFO To PAT
CFO To PAT%
208.4188.5197.2182.4222.6213.8140.8260.9279.1218.6183.5
CFO To EBITDA
CFO To EBITDA%
89.487.473.971.484.585.554.1104.282.195.174.9

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,5303,7253,7813,6804,8777,4366,1145,1525,6706,4606,5637,583
Price To Earnings
Price To Earnings
14.919.622.019.123.531.128.622.726.618.016.919.6
Price To Sales
Price To Sales
1.21.61.61.41.82.41.81.41.41.51.41.5
Price To Book
Price To Book
2.63.63.02.63.24.43.42.62.72.72.32.6
EV To EBITDA
EV To EBITDA
7.610.29.08.39.212.811.610.08.98.47.68.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
44.243.144.544.245.846.143.241.344.445.846.546.5
OPM
OPM%
19.018.319.218.420.219.816.815.618.219.820.319.8
NPM
NPM%
8.18.57.27.27.77.96.56.35.48.68.37.8
ROCE
ROCE%
19.719.217.217.815.416.012.711.712.817.015.615.6
ROE
ROE%
17.918.813.914.113.814.412.111.610.115.413.813.8
ROA
ROA%
8.68.77.17.87.58.16.76.35.59.18.08.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,5303,7253,7813,6804,8777,4366,1145,1525,6706,4606,5637,583
Price To Earnings
Price To Earnings
14.919.622.019.123.531.128.622.726.618.016.919.6
Price To Sales
Price To Sales
1.21.61.61.41.82.41.81.41.41.51.41.5
Price To Book
Price To Book
2.63.63.02.63.24.43.42.62.72.72.32.6
EV To EBITDA
EV To EBITDA
7.610.29.08.39.212.811.610.08.98.47.68.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
44.243.144.544.245.846.143.241.344.445.846.546.5
OPM
OPM%
19.018.319.218.420.219.816.815.618.219.820.319.8
NPM
NPM%
8.18.57.27.27.77.96.56.35.48.68.37.8
ROCE
ROCE%
19.719.217.217.815.416.012.711.712.817.015.615.6
ROE
ROE%
17.918.813.914.113.814.412.111.610.115.413.813.8
ROA
ROA%
8.68.77.17.87.58.16.76.35.59.18.08.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
- **EPL is the world’s largest manufacturer of laminated plastic tubes - the squeezable packaging that holds toothpaste, face cream, ointments and gels - supplying over 9 billion tubes a year from 21 factories across 11 countries.** Founded in 1982 as Essel Packaging with a single plant in Vasind, India, it grew by acquiring a Swiss tube business in 2001 and was itself bought by Blackstone in 2019, rebranding as EPL. The recurring approach is to lock in global consumer-goods giants with long-term contracts, then use the steady cash flows to build the next capability - backward integration into making its own laminate sheets, a widening portfolio of recyclable tubes, and a deliberate shift from oral care into higher-margin beauty and pharmaceutical packaging. # Business segments Four geographic engines, each a regional tube-making and selling operation - AMESA, Americas, Europe and East Asia Pacific - that together form a single global packaging business built on the same product, the same customers and the same manufacturing playbook. ## 1. AMESA: the anchor region where the company makes its own raw material **India and Egypt house nine plants and the group’s laminate-sheet factories, so this region supplies both finished tubes to local customers and semi-finished laminate to other EPL regions.** - **Backward-integrated from the start** - the Indian plants buy polymer granules (LLDPE and HDPE, both crude-oil derivatives), extrude them into plastic film, laminate the film into multi-layer sheets, then supply those sheets to other plants which convert them into printed tubes. That eliminates a middleman and gives the region a structural cost advantage over competitors who buy ready-made laminate. - **The laminate hub for the group** - film produced in India and China is dynamically allocated to other EPL regions, so AMESA’s factories do not just serve their own customers; they feed the global network. - **Oral care is the bedrock, but beauty is catching up** - India still sells heavily into toothpaste, yet the region is also where EPL first built in-house cap manufacturing as a cost-containment move, a capability that now supports the higher-margin beauty and pharma segments. ## 2. Americas: the local supplier shielded from tariffs **Four plants in the USA, Mexico, Colombia and Brazil make tubes inside the trade borders of their biggest customers, so most revenue never crosses a customs line.** - **Made in the USA, for the USA** - the American factory supplies the US market directly; less than 5% of EPL’s total revenue is exported into the US, insulating the business from tariff swings. Where duties do apply, contracts with most customers pass the cost straight through. - **Brazil is the growth engine** - a greenfield plant built to serve an anchor customer now meets 100% of that customer’s demand and has already won orders from other multinationals and local brands, running high-speed SMART tube lines. The ramp-up is ahead of plan, and EPL calls itself the only strategic global tube supplier in the country. - **Colombia and Mexico round out the footprint** - the Colombian operation was reorganised in 2022 when a legacy subsidiary was liquidated, but tube-making continues through the existing entity. Together the four Americas plants employ about 900 people. ## 3. Europe: the beauty-market beachhead with a cost turnaround **Three plants in Poland and Germany target the world’s largest beauty and cosmetics market, where EPL holds single-digit share and has been restructuring to earn mid-teen margins.** - **Shifted production east to cut costs** - manufacturing was moved from high-cost Germany to Poland, where labour is cheaper and the plant runs seven days a week instead of five, unlocking 40% more capacity from the same assets. Headcount was reduced and the organisation streamlined alongside the physical move. - **Extruded as well as laminated** - the European units make both laminated and extruded plastic tubes, giving them a product range that matches local demand in beauty and pharma. - **A small share of a very large pie** - Europe is the biggest beauty and cosmetics market globally, and EPL’s single-digit position means the region is treated as a growth opportunity rather than a mature cash cow. A sales office in the UK supports the continental factories. ## 4. East Asia Pacific: the China-anchored platform now expanding south **Five factories in China and one in the Philippines supply the Asia-Pacific consumer market, with a new greenfield plant in Thailand that started shipping in late 2025.** - **China and India both manufacture films** - the company dynamically manages film production allocation between the two countries to optimise cost and supply routes. - **Thailand opens a new front** - a wholly-owned subsidiary incorporated in February 2025 began customer supplies during the third quarter of the fiscal year, extending EPL’s manufacturing reach into Southeast Asia beyond the Philippine base. - **Export bridge to Australia** - the region also serves Australia through exports, adding volume without requiring a dedicated factory. The EAP region employs about 1,000 people. # Group structure and partners **EPL is an Indian-listed company controlled by a Blackstone fund, soon to become a co-promoted entity with Indorama Ventures through a merger that will add rigid PET packaging to the tube business.** - **Blackstone brought scale and the EPL name** - Blackstone Inc. acquired the company (then Essel Propack) in 2020 through Epsilon Bidco Pte. Ltd., which held roughly 75% at the time; the business was rebranded EPL in 2020. - **Indorama is becoming a co-promoter** - in May 2025, Epsilon Bidco sold a 24.9% stake to Indorama Netherlands B.V., leaving Blackstone with 26.4% and Indorama with 24.9%. The two shareholders are now bringing Indorama’s Indian rigid-packaging subsidiary (Indovida, which makes PET preforms, bottles and closures) into EPL via a scheme of amalgamation approved by the board in March 2026. - **The merged entity will be a packaging powerhouse** - pro-forma revenue across the combined group is INR 83.8 billion, with 40 factories in 17 countries and roughly three-quarters of revenue from emerging markets. Post-merger, Indorama Ventures will hold 51.8% and Blackstone 16.6%, and the Competition Commission of India has already cleared the deal. - **Earlier acquisitions were folded in** - EPL bought a 72.46% stake in Creative Stylo Packs (an Indian maker of corrugated boxes, laminated tubes and caps) in 2021 and amalgamated it in 2022, adding complementary capacity in personal-care and pharma packaging.

Documents — EPL Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/juxvlfcr45e9s6kbnpaqokhd.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/284tyysgpgrlv95cip3rrofg.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/lctahr0lhka3ifpwnzrcn81b.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/yctdnzhl1xp0wzpaasftvfzp.pdf
  • Q1 FY2026 Earnings Call Transcript (Jun 2025, PDF): https://www.stockscans.in/document/szzmi2ylxab270plbdnytclc.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/z21dqsfwusqqwyu91nrgngv6.pdf
  • Q3 FY2025 Earnings Call Transcript (Dec 2024, PDF): https://www.stockscans.in/document/vuzjjj69is3ythziqymkpk0c.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/9zlvdqfpgw9up755g4indzdx.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/536bp37qcjpczb6jm8p1rj4e.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/kohz18lajp18mt3sniasc8d2.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/prytxwsbxsdi8bb7pa7m4yna.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/i7sqnos77jbp3ghlpjrfr3ph.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/96rlyk48vy2xsoph11h8ydr2.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/azzrvdm9qp4xdwk1w0j4z05o.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/tx60ig6mzjgykit8lk4bkjib.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/n89shcb94vpwfqmlcq70kyi4.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/8r94kuhmmqg5vepk3ofe9b4j.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/fhejgxfneo0goq1t71jjxecg.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/5s3ofg4xmp9tf383jmj1r0jk.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/okktmyz5i5gs07mnbp4hfqw3.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/gw5z74sfvq8k60n7k5yei6uc.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/ur3lxslgxueq7nuwk32i1wzb.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/4qo4voor3aha04ihxvc2clyi.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/xcj2c9x4qijhx8hz6un26q4t.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/y1jea7nzyusp81tl4yp6m8yv.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/v3bbbt16osmi4g0y1cvj73hy.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/u63bsoiw10ibrrjgv3zceqpu.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/oot621oiipriw9kzi62dm1ye.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/uucp7huqogvdooe28gtc3gjw.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/iawtcpp3lqkkas234tgwfe03.pdf

Concall Transcript Summaries — EPL Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3AEPL/transcript-notes/202606/juxvlfcr45e9s6kbnpaqokhd.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3AEPL/transcript-notes/202603/284tyysgpgrlv95cip3rrofg.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3AEPL/transcript-notes/202512/lctahr0lhka3ifpwnzrcn81b.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3AEPL/transcript-notes/202509/yctdnzhl1xp0wzpaasftvfzp.pdf
  • Q1 FY2026 Concall Transcript Summary (Jun 2025): https://www.stockscans.in/company/NSE%3AEPL/transcript-notes/202506/szzmi2ylxab270plbdnytclc.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3AEPL/transcript-notes/202503/z21dqsfwusqqwyu91nrgngv6.pdf
  • Q3 FY2025 Concall Transcript Summary (Dec 2024): https://www.stockscans.in/company/NSE%3AEPL/transcript-notes/202412/vuzjjj69is3ythziqymkpk0c.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3AEPL/transcript-notes/202409/9zlvdqfpgw9up755g4indzdx.pdf